$0.26
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

IM Cannabis Corp. engages in the production and sale of medical cannabis products. The firm's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The firm's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.
Country

IL

CEO

Mr. Oren Shuster

IPO date

2019

Employees

44

ISIN

CA44969Q4060

Key stats

Open

$0.64

Volume

100.73M

Market cap

$1.76M

Prev. close

$0.26

Impl / hst vl

-

Open interest

$0.00

$0.23

Day’s Range

$0.73

$0.21

52W Range

$1.56

Valuation

27
Valuation score
Overvalued
P/E
-
P/S
0.14
P/B
1.43
Current ratio
0.72
Debt / Equity
2.70
ROE
-79.48%
Gross margin
27.58%
Income growth
-127.20%
FCF growth
-205.53

Analysts estimates

Consensus rating
Buy

The average rating from top 4 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$2.48
The top 3 analysts forecasts that 12-month price may increase by 855.58%, with a low of $2.46 and a high of $2.56
$2.46
Low
$2.48
Avg
$2.56
High
Current price

Earnings

Q1 ‘25 revenue
$8.93M
Q1 ‘25 net income
$196.50K
Revenue
Net income
Previous EPS
-$0.86
Estimate EPS
$0.00
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply